Introduction: rationale for using drotrecogin alfa (activated) in patients with severe sepsis-Reference-Cited by-同舟云学术

Introduction: rationale for using drotrecogin alfa (activated) in patients with severe sepsis

Published:2002-12 Issue:6 Volume:184 Page:S5-S10
ISSN:0002-9610
Container-title:The American Journal of Surgery
language:en
Short-container-title:The American Journal of Surgery

Author:

Dhainaut Jean-François

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference57 articles.

1. Epidemiology of severe sepsis in the United States;Angus;Crit Care Med,2001

2. Davies A, Green C, Hutton J, Chinn C. Severe sepsis: a European estimate of the burden of disease in ICU. Intensive Care Med 2001;27(suppl):S284. Abstract 581

3. Age-specific incidence and outcome of sepsis in the US;Linde-Zwirble;Crit Care Med,1999

4. The sirens’ songs of confirmatory sepsis trials;Natanson;Crit Care Med,1998

5. Deaths;Murphy;Natl Vital Stat Rep,2000

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drotrecogin alfa;Meyler's Side Effects of Drugs;2016

2. Critical Role of Activated Protein C in Early Coagulopathy and Later Organ Failure, Infection and Death in Trauma Patients;Annals of Surgery;2012-02

3. Protein C Depletion Early After Trauma Increases the Risk of Ventilator-Associated Pneumonia;Journal of Trauma: Injury, Infection & Critical Care;2009-12

4. Anticoagulant proteins;Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions;2006

5. A serine proteinase inhibitor isolated from Tamarindus indica seeds and its effects on the release of human neutrophil elastase;Life Sciences;2005-05